Learn how genes can make certain medications toxic, and why pharmacogenetic testing still isn’t routinely used to prevent serious reactions.

FDA recalls of carbamazepine and acamprosate calcium include nationwide Class II recalls involving black spots and ...

Could some cancer patients get the same benefit from less medication? Researchers are challenging standard doses.

Rapamycin has become a favorite among longevity enthusiasts. Now, some fertility specialists are prescribing it off-label to improve IVF outcomes, while others say the evidence isn't strong enough to ...

A new oral PCSK9 inhibitor may lower cholesterol by more than half when added to statins and other existing treatments, but whether it prevents heart attacks and strokes remains unknown ...

Peptide researcher Joshua Kritzer explains why promising mouse studies and online testimonials aren't enough to prove a treatment is safe — or effective ...

New FDA-approved medications and older repurposed drugs are expanding treatment choices for women seeking relief from hot flashes, sleep problems, mood changes, and other symptoms ...

For millions of women, fatigue, brain fog and feeling “off” is often dismissed as stress, depression or aging. New guidance suggests low ferritin could be the overlooked culprit ...

Stevens-Johnson syndrome is frequently misdiagnosed in its early stages, delaying treatment and increasing the risk of life-altering complications ...